Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2 - Quiz - MDSpire

Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2

  • By

  • Ana de Souza Santos

  • Leonardo Pereira de Araújo

  • Diego Jose Belato Orts

  • Hernan Hermes Monteiro da Costa

  • Kely Catarine Matteucci

  • Evandro Neves Silva

  • Karen Cristina Oliveira

  • Giovane Galdino

  • Carlos Roberto Prudencio

  • Patrícia Paiva Corsetti

  • Leonardo Augusto de Almeida

  • July 16, 2026

Share

Original Source(s)

Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2

  • by Ana de Souza Santos, Leonardo Pereira de Araújo, Diego Jose Belato Orts, Hernan Hermes Monteiro da Costa, Kely Catarine Matteucci, Evandro Neves Silva, Karen Cristina Oliveira, Giovane Galdino, Carlos Roberto Prudencio, Patrícia Paiva Corsetti, Leonardo Augusto de Almeida

  • July 16, 2026

Related Content

Letter to the editor regarding ‘clinical characteristics and factors associated with in-hospital post-surgical mortality in COVID-19 patients at a tertiary care center in Karachi, Pakistan

Low Weight Linked to Severe Pediatric COVID

Brazilian pediatric intensive care unit study found underweight status was associated with respiratory complications, longer hospitalization, and mortality among critically ill patients with COVID-19.

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.